Compare PARR & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PARR | PAHC |
|---|---|---|
| Founded | 1984 | 1946 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Integrated oil Companies | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.1B |
| IPO Year | 2000 | 2014 |
| Metric | PARR | PAHC |
|---|---|---|
| Price | $61.85 | $54.49 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 5 | 3 |
| Target Price | ★ $57.00 | $34.33 |
| AVG Volume (30 Days) | ★ 1.6M | 263.2K |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 0.90% |
| EPS Growth | 1313.56 | ★ 1883.33 |
| EPS | ★ 7.16 | 1.32 |
| Revenue | ★ $2,443,066,000.00 | $833,350,000.00 |
| Revenue This Year | N/A | $17.03 |
| Revenue Next Year | $4.73 | $3.82 |
| P/E Ratio | ★ $8.92 | $40.37 |
| Revenue Growth | ★ 30.99 | 4.12 |
| 52 Week Low | $12.04 | $16.16 |
| 52 Week High | $66.75 | $57.62 |
| Indicator | PARR | PAHC |
|---|---|---|
| Relative Strength Index (RSI) | 65.93 | 58.41 |
| Support Level | $34.55 | $37.09 |
| Resistance Level | N/A | $56.14 |
| Average True Range (ATR) | 3.56 | 2.50 |
| MACD | 0.46 | 0.08 |
| Stochastic Oscillator | 69.94 | 70.69 |
Par Pacific Holdings Inc is an oil and gas company that manages and maintains interests in energy and infrastructure businesses. The company has three reportable segments namely Refining, Under its refining business, the company produces ultra-low-sulfur diesel, gasoline, jet fuel, marine fuel, LSFO, and other associated refined products. Its Retail includes operation licenses out brands to serve the retail consumer. Through the Logistics segment, crude shipments are delivered to the refineries, in addition to finished products that are exported. It generates maximum revenue from the Refining segment.
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.